EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of the mechanism of antimicrobial action of the gold(I) compound auranofin in Gram-positive and Gram-negative bacteria

Laísa Quadros Barsé, Agnes Ulfig, Marharyta Varatnitskaya, Melissa Vázquez-Hernández, Jihyun Yoo, Astrid M Imann, Natalie Lupilov, Marina Fischer, Katja Becker, Julia E Bandow, Lars I Leichert iD

Microbiology Spectrum · 05.11.2024 · 12 (11)

DOI: 10.1128/spectrum.00138-24 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Microbiology Spectrum, erschienen am 05.11.2024. Verfasst von Laísa Quadros Barsé und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty, Institute of Biochemistry and Pathobiochemistry-Microbial Biochemistry, Ruhr University Bochum, Bochum, Germany. Hauptthemen laut MEDLINE: Auranofin, Bacillus subtilis, Escherichia coli, Anti-Bacterial Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG), RUB | Medizinische Fakultät, Ruhr-Universität Bochum (Faculty of Medicine at Ruhr-Universität Bochum), Land Nordrhein-Westfalen (NRW).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While highly effective at killing Gram-positive bacteria, auranofin lacks significant activity against Gram-negative species for reasons that largely remain unclear. Here, we aimed to elucidate the molecular mechanisms underlying the low susceptibility of the Gram-negative model organism Escherichia coli to auranofin when compared to the Gram-positive model organism Bacillus subtilis . The proteome response of E. coli exposed to auranofin suggests a combination of inactivation of thiol-containing enzymes and the induction of systemic oxidative stress. Susceptibility tests in E. coli mutants lacking proteins upregulated upon auranofin treatment suggested that none of them are directly involved in E. coli ’s high tolerance to auranofin. E. coli cells lacking the efflux pump component TolC were more sensitive to auranofin treatment, but not to an extent that would fully explain the observed difference in susceptibility of Gram-positive and Gram-negative organisms. We thus tested whether E. coli ’s thioredoxin reductase (TrxB) is inherently less sensitive to auranofin than TrxB from B. subtilis , which was not the case. However, E. coli strains lacking the low-molecular-weight thiol glutathione, but not glutathione reductase, showed a high susceptibility to auranofin. Bacterial cells expressing the genetically encoded redox probe roGFP2 allowed us to observe the oxidation of cellular protein thiols in situ . Based on our findings, we hypothesize that auranofin leads to a global disturbance in the cellular thiol redox homeostasis in bacteria, but Gram-negative bacteria are inherently more resistant due to the presence of drug export systems and high cellular concentrations of glutathione. IMPORTANCE Auranofin is an FDA-approved drug for the treatment of rheumatoid arthritis. However, it has also high antibacterial activity, in particular against Gram-positive organisms. In the current antibiotics crisis, this would make it an ideal candidate for drug repurposing. However, its much lower activity against Gram-negative organisms prevents its broad-spectrum application. Here we show that, on the level of the presumed target, there is no difference in susceptibility between Gram-negative and Gram-positive species: thioredoxin reductases from both Escherichia coli and Bacillus subtilis are equally inhibited by auranofin. In both species, auranofin treatment leads to oxidative protein modification on a systemic level, as monitored by proteomics and the genetically encoded redox probe roGFP2. The single largest contributor to E. coli ’s relative resistance to auranofin seems to be the low-molecular-weight thiol glutathione, which is absent in B. subtilis and other Gram-positive species.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AuranofinBacillus subtilisEscherichia coliAnti-Bacterial AgentsMicrobial Sensitivity TestsGram-Positive BacteriaGram-Negative BacteriaThioredoxin-Disulfide ReductaseEscherichia coli ProteinsOxidative StressBacterial ProteinsMembrane Transport ProteinsBacterial Outer Membrane Proteins

Stichwörter der Autor:innen

Bacillus subtilisEscherichia coliauranofindrug repurposinggoldproteomicsthioredoxin reductase

Substanzen

AuranofinAnti-Bacterial AgentsThioredoxin-Disulfide ReductaseEscherichia coli ProteinsBacterial ProteinstolC protein, E coliMembrane Transport ProteinsBacterial Outer Membrane Proteins

Autor:innen und Institutionen

  • Medical Faculty, Institute of Biochemistry and Pathobiochemistry-Microbial Biochemistry, Ruhr University Bochum, Bochum, Germany.
  • Faculty of Biology and Biotechnology, Applied Microbiology, Ruhr University Bochum, Bochum, Germany.
  • Institute of Electrical Engineering and Applied Sciences-Molecular Biology, Westphalian University of Applied Sciences, Recklinghausen, Germany.
  • Interdisciplinary Research Center, Justus Liebig University Giessen, Giessen, Germany.

ORCID-Profile: Lars I Leichert

Förderung

  • Deutsche Forschungsgemeinschaft (DFG)
  • RUB | Medizinische Fakultät, Ruhr-Universität Bochum (Faculty of Medicine at Ruhr-Universität Bochum)
  • Land Nordrhein-Westfalen (NRW)

Zitieren

APA

Quadros Barsé, L., Ulfig, A., Varatnitskaya, M., Vázquez-Hernández, M., Yoo, J., Imann, A. M., Lupilov, N., Fischer, M., Becker, K., Bandow, J. E., & Leichert, L. I. (2024). Comparison of the mechanism of antimicrobial action of the gold(I) compound auranofin in Gram-positive and Gram-negative bacteria. Microbiology Spectrum, 12(11). https://doi.org/10.1128/spectrum.00138-24

Vancouver

Quadros Barsé L, Ulfig A, Varatnitskaya M, Vázquez-Hernández M, Yoo J, Imann AM, et al. Comparison of the mechanism of antimicrobial action of the gold(I) compound auranofin in Gram-positive and Gram-negative bacteria. Microbiology Spectrum. 2024;12(11). doi:10.1128/spectrum.00138-24

BibTeX
@article{QuadrosBars2024,
  author = {Quadros Barsé, Laísa and Ulfig, Agnes and Varatnitskaya, Marharyta and Vázquez-Hernández, Melissa and Yoo, Jihyun and Imann, Astrid M and Lupilov, Natalie and Fischer, Marina and Becker, Katja and Bandow, Julia E and Leichert, Lars I},
  title = {Comparison of the mechanism of antimicrobial action of the gold(I) compound auranofin in Gram-positive and Gram-negative bacteria},
  journal = {Microbiology Spectrum},
  year = {2024},
  volume = {12},
  number = {11},
  doi = {10.1128/spectrum.00138-24}
}
Kostenlos starten →